• Utah-based Diamond Lake Minerals is developing its vision of an umbrella parent company that not only holds a variety of industry-crossing subsidiaries, but that also serves as a gateway for cautious investors looking to dip a toe into digital assets
• The company’s vertically integrated portfolio will include holdings that are infused with security token offerings registered with the U.S. Securities and Exchange Commission
• Diamond Lake views its digital asset-in-a-real world asset gateway as a hedge against market volatility, especially for real estate properties that may be over-leveraged and struggling to stay afloat while seeking favorable lending terms
• A recent spate of bad debt concerns in the commercial real estate arena has raised warnings about bank exposure and a possible run against uninsured financiers

Recent concerns about a global wave of commercial real estate loan defaults, described as potentially the worst crisis for the sector since the 2008 bursting of the global financial bubble, is leading banks to proactively assure investors about their ability to absorb potential losses, while investors scrutinize loan books for signs of insecurity (https://ibn.fm/v5SpF).

As investors worry, multi-strategy operating company Diamond Lake Minerals (OTC: DLMI) is pursuing a course that offers investors regulatory oversight in the digital asset market and a potential solution to “underwater” real estate property owners that could offset volatility in the market.

Diamond Lake CEO Brian J. Esposito commented on the company’s solution for helping people generate wealth from both digital and traditional securities in a Jan. 31 interview with Proactive Investors (https://ibn.fm/2BXza), highlighting the role real estate may play in the growth of fractional security token offering (“STO”) ownership of real assets.

“A lot of these properties are highly leveraged — they can be overvalued. And they’re sitting on balance sheets somewhere that have a potential risk factor, especially for banks that are holding this paper,” Esposito said. “It’s very hard to create liquidity for those building holders, or those property holders. So if you were to take that building that you couldn’t get rebank financing … on that property, but it does have the ability to earn and create value, well then you can open it up to millions of people around the world through a proper security token offering and (do) it under the right rules and regulations, where now you have all kinds of potential liquidity and capital coming in.”

Esposito said offsetting market volatility by opening commercial properties up to fractional ownership is Diamond Lake’s approach to creating a “giant funnel of liquidity and access to capital that was never able to be accessed before.”

The company is saying, “Hey, I don’t want to see the real estate market collapse, … because of all those assets in the trillions … that’s on balance sheets around the world,” he added. “If that starts to crumble, it hurts everybody — it hurts the local economy, it hurts the stock market.”

Diamond Lake is creating a powerful parent umbrella company with quality, industry-agnostic assets, and imbuing those vertically integrated subsidiaries with U.S. Securities and Exchange Commission (“SEC”)-registered STOs via the regulated security token exchange INX.

Diamond Lake’s gateway therefore is not only to the real asset holdings in sectors ranging from entertainment to real estate to health care and medicine, but also to the emerging market sector that digital assets comprise.

“We want to always create responsible business transactions. We like to do these things with seasoned entrepreneurs and professionals who’ve got great accounting and regulatory and compliance,” Esposito said. “Anything that’s a really good asset for our balance sheet and anything that we can create great profitability and returns for, that’s what we want under our DLMI umbrella.”

In addition, for information on the company’s security token SEC regulated exchange partner INX, and the development of the INX Way, visit https://www.inx.co/inx-ebook/. This free security token bible, written with the SEC on the rollout of security tokens and the future of digital assets, will greatly deepen your understanding of security tokens.

For more information, visit the company’s website at www.DiamondLakeMinerals.com or LinkedIn page at www.LinkedIn.com/company/Diamond-Lake-Minerals/.

NOTE TO INVESTORS: The latest news and updates relating to DLMI are available in the company’s newsroom at https://ibn.fm/DLMI

• The Activist Investor Conference will take place on March 21, 2024, at 237 Park Avenue, one of Manhattan’s premiere meeting venues
• The 14th annual edition of the conference features investors, corporate board members and governance experts, advisory firms, proxy solicitors and finance professionals who will delve into the latest trends within shareholder activism
• This year’s conference features a number of keynote presentations by experts in the field, including Patrice Bonfiglio, Sean Donohue, and Jon Feldman

Shareholder activism emerged in the 1970s and 1980s as a tool to drive the process of price formation, improve corporate governance and defend minority shareholder interests. Today, in a market environment characterized by a surge in the number of passive investors and a reduction in the diversity of research and market participants, the importance of shareholder activism may be greater than ever.

Corporate engagement and shareholder activism has become increasingly crucial within the context of modern financial markets.

With over 20 years of experience and having hosted over 200 conferences, seminars and webcasts on a variety of financial topics, DealFlow Events is gearing up to host the upcoming Activist Investor Conference 2024 on March 21, 2024 in New York City. Now in its 14th year, the Activist Investor Conference delivers an invaluable forum for discussion of governance-related issues by savvy finance professionals seeking to improve the fortunes of the companies in which they’ve invested.

Covering a wide range of topics, including ‘Value Investing’, ‘Trending Legal Issues Facing Shareholder Activism’, ‘How the Lone Dissident can Prevail’ and the ‘Impact of corporate relations with shareholders on an activist campaign’, the conference presents a slate of keynote presentations throughout the day. Speakers include Patrice Bonfiglio, President at Sarissa Capital; Sean Donohue, Co-Chair of Shareholder Activism and Takeover Defense at Paul Hastings LLP; Jon Feldman, Partner at Goodmans; Adam Kommel, Shareholder Activism Development Lead at Bloomberg LP; and Michael Levin, Founder of The Activist Investor, among several other experts in the field.

Conference attendees will be in an enviable position to hear key insights into the world of activist investing. Ranging from understanding the evolution of shareholder and management rights over time, to learning about board size, short attacks and activist strategy, investors will learn about what really matters within activist investing today as well as what to expect in the future.

For additional details about the Activist Investor Conference, including registration, visit: https://www.activistinvestorconference.com.

• SOBRsafe recently published three case studies that empirically demonstrate the performance of its alcohol screening technology, SOBRcheck(TM), based on customer data, experiences, and results
• SOBRcheck can be used as a safe, convenient, and fast replacement for cumbersome and unhygienic breathalyzers 
• One case study shows that SOBRcheck enabled TerraTech to achieve a 100% pass rate per week against an estimated industry average weekly violator rate of between 60% and 70%
• By deploying SOBRcheck, Big Horn County has been able to provide cost-effective alcohol monitoring services for more than 100 community members, while Alternatives Inc. has achieved 4x faster throughput at check-in/check-out
• SOBRsafe CEO recently provided a comprehensive update on the company in a fireside chat video

A disruptive company leveraging advanced alcohol detection approaches and technologies, SOBRsafe (NASDAQ: SOBR) is a provider of next-generation touch-based alcohol screening, detection, and monitoring solutions, as well as real-time reporting software. Among these revolutionary solutions is SOBRcheck(TM).

A stationary identification and alcohol screening/monitoring technology launched in 2021, SOBRcheck detects and instantaneously reports the presence of alcohol emitted through the pores of a fingertip. It is equipped with a biometric identifier that automatically confirms the user’s identity and hardcodes this identification information, as well as the date and time of the screening, into the automatically generated reports, thus boosting reliability.

SOBRcheck can be used at the entry points of job sites, as TerraTech Services, a national leader in oilfield services and logistics, has done since November 2022, following a successful pilot program. In this pilot program, TerraTech worked with SOBRsafe to deploy the SOBRcheck platform at the points of entry of two of its 16 sites.

The results were remarkable, with TerraTech experiencing “tremendous success,” as a Health, Safety, and Environment Manager at the company put it. TerraTech achieved 100% compliance from employees at both pilot sites within a short period, so much so that after a month of daily testing, the company was confident of SOBRcheck’s effectiveness and subsequently worked with SOBRsafe to install the SOBRcheck devices at the remaining 14 sites.

This larger-scale deployment result was as impactful as the first, with one location witnessing a remarkable 100% decrease in alcohol-positive results within a two-week period. Overall, TerraTech, which screens employees for alcohol three times a day, had logged over 80,000 scans into the SOBRsafe portal as of December 31, 2023, achieving an effective 100% pass rate per week. In contrast, TerraTech estimates that the industry average weekly violator rate stands at 60-70%.

SOBRcheck can also be deployed to replace traditional breathalyzer tests, which require dedicated staff – because they have to be manually administered – and are expensive, cumbersome, time-consuming, and unhygienic. For instance, Big Horn, Montana’s 6th largest county in landmass, which previously used traditional breathalyzer tests for its 24/7 Sobriety Program, turned to SOBRsafe in July 2023, initially deploying the SOBRcheck technology in two locations within the County building.

Since deployment, the screening has followed – and still follows – an unstaffed testing procedure in which each participant simply completes their alcohol screen in about 10 seconds. This marks an improvement from the past when it could take hours for County staff to process a group of individuals. In conjunction with SOBRsafe, Big Horn County has created an efficient, cost-effective program for court-mandated, passive alcohol screening outside of major metro areas. The program is not only hygienic and convenient, but it also improves safety, reduces costs, and enhances accountability and accessibility. As of December 2023, for example, it had achieved a 92% total pass rate, up from 67% in July (https://ibn.fm/4GAe5).

“In providing cost-effective monitoring services for more than 100 community members, SOBRcheck has been a big win for our county staff, taxpayers, and participants,” the second case study quotes Big Horn County Misdemeanor Probation and Pre-Trial Services Officer as saying. “Both participants and our staff are given back hours in their days to be more productive. I believe this will also lead to more successful results for all those in court-mandated programs, as it is no longer cost-prohibitive to participate.”

On its part, Alternatives Inc., a leader in community corrections and re-entry strategies, installed SOBRcheck devices at the Alpha House, a men’s pre-release center, and Passages, a residential program for women comprising of a pre-release center, an assessment center, and a drug and alcohol treatment program. SOBRcheck delivers in 10 seconds what the observed screening procedure using a traditional breathalyzer would deliver in 45 seconds, with the high number of screens compounding the time savings.

“Across 2,073 scans, it would have taken the Alternatives team approximately 25 hours via their observed breathalyzer process versus less than six hours with SOBRcheck – up to 4x faster throughput [at check-in/check-out],” explains the third case study (https://ibn.fm/mErml). Thus, SOBRsafe’s revolutionary device is much faster than the traditional test.

SOBRsafe has also recently provided a comprehensive video update on the company from Chairman and CEO Dave Gandini (https://ibn.fm/mN0MV). In the video, Gandini discussed the company’s suite of solutions, target markets (including justice and behavioral health), out-licensing prospects, integration opportunities, supply chain, product fulfillment, customer service, a digital and social media initiative to drive online SOBRsure sales at www.SOBRstore.com, and more. To watch the video, please visit https://ibn.fm/DSidn (registration required).

For more information, visit the company’s website at www.SOBRsafe.com.

NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://ibn.fm/SOBR

• Lexaria, a global innovator in drug delivery platforms to enhance bioavailability, announced recently that it will focus on GLP-1 applications for diabetes and weight loss for the 2024 calendar year
• Chris Bunka, Lexaria’s CEO, has expressed his confidence in the company’s direction, reiterating the intention to demonstrate the superior performance of GLP-1 drugs processed with its patented DehydraTECH(TM) technology
• The company looks to build on the success of the early-stage results achieved in 2023, and looks to embark on two human pilot studies, a multi-arm 12-week animal chronic study, a human chronic weight-loss and diabetes study, as well as a multi-month stability testing of DehydraTECH GLP-1

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced its 2024 R&D plans, with emphasis on GLP-1 investigations. GLP-1 agonists (glucagon-like peptide 1) is a class of drugs used for diabetes and weight loss.

This comes hot on the heels of a successful, active year of R&D in 2023, a year that saw significant strides in developing its patented DehydraTECH(TM) technology including its new foray into GLP-1 drugs. Chris Bunka, Lexaria’s CEO, expressed his confidence and overall optimism in the company’s new direction, reiterating the company’s intention to demonstrate the superior pharmacokinetics and safety/efficacy performance of GLP-1 drugs when formulated and processed with DehydraTECH (https://ibn.fm/92pzS).

In 2023, DehydraTECH showed positive results in its 8-week study that involved 32 diabetic rodents. The study showed that DehydraTECH-CBD lowered triglyceride levels and body weight differential over the eight weeks, positive results that would also be replicated in its other studies including, but not limited to, hypertension, human hormones, and the overall reduced risk of oral nicotine. This laid the groundwork for Lexaria to explore a new class of molecules it had never worked on before, ultimately quietly launching its top-priority and unpublicized early-stage work program – GLP-1- for weight loss and diabetes control.

In the words of Mr. Bunka, this was a “high-risk program,” mainly because this class of drugs is considered “large molecules,” yet all of Lexaria’s previous investigations were concentrated on “small molecules.” However, by the end of November and early January 2024, the company reported positive interim and final human pilot study results using a single semaglutide dose of a Rybelsus(R) tablet to a matching dose from Rybelsus(R) that had been compound formulated in capsule form using DehydraTECH processing technology enhancements. This was a massive milestone for Lexaria, with Bunka describing the results as “surprising.” Of note was that DehydraTECH processing delivered a statistically-significant higher proportion of the semaglutide and did so more quickly, ultimately having a statistically-significant impact on blood sugar.

GLP-1 drugs have been receiving rising interest recently. Having received FDA approvals as recently as 2021 and 2022, mainly given its health benefits and potential market size, Lexaria understands that this could be the next best thing, hence its focus on this drug class.

“Our R&D plans for 2024 are very tightly focused and will be concentrated mainly on GLP-1 investigations,” noted Mr. Bunka.

“Given the overwhelming interest in the GLP-1 sector, this will be a main focus. We are not at this time planning additional 2024 research in the antiviral, nicotine, or PDE5 sectors. We have solid early-stage data in each of those areas that will allow us to build upon those at the right time,” he added.

Mr. Bunka has reiterated that 2024 will be the year that Lexaria’s hard work will prove its worth. He looks to follow up on the positive early-stage results achieved in 2023, even as it embarks on two human pilot studies, a multi-arm 12-week animal chronic study, a human chronic weight-loss and diabetes study, as well as a multi-month stability testing of DehydraTECH GLP-1. Mr. Bunka is confident that its focus on GLP-1 drugs will yield this outcome.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• The CDC estimates that the prevalence of ASD in the United States is 1 in 36 children, with no approved pharmacologic treatments targeting the cause and symptoms
• PaxMedica is developing novel anti-purinergic therapies for the treatment of ASD and other serious conditions with intractable neurologic symptoms, and is on a promising path to address the unmet medical needs and bring hope to millions
• Company CEO Howard Weisman recently shared insights into PaxMedica’s achievements and advancements in a Fireside Chat video, underscoring the company’s commitment to groundbreaking therapies and transformative solutions

The prevalence of autism spectrum disorder (“ASD”) in the United States has risen to approximately 1 in 36 children, according to the Centers for Disease Control and Prevention (“CDC”). There are currently no approved pharmacologic treatments that target the causes and symptoms of ASD – the only treatment available on the market addresses symptoms of the condition rather than targeting the pathophysiology itself (https://ibn.fm/2adEF).

ASD is characterized by extreme versions of the processes governing the ability to focus attention and filter out sensory input. These processes often bring a wide range of special abilities, including the ability to hyperfocus on specific tasks, but they make normal everyday interactions and activities more challenging. These challenges don’t only affect those with ASD but the family and friends around them.

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of ASD and other serious conditions with intractable neurologic symptoms, is on a promising path to address the unmet medical needs and bring hope to millions. The company’s CEO, Howard Weisman, recently shared insights into PaxMedica’s recent achievements and advancements in a Fireside Chat video, underscoring the company’s commitment to groundbreaking therapies and transformative solutions. The full video can be found on the company’s website or through PaxMedica’s YouTube channel (https://ibn.fm/G743s).

Mr. Weisman discussed the following key attributes during the video:

• A regulatory update with insights from the recent FDA Type-B meeting on October 25, 2023, shed light on the regulatory pathway for PAX-101 for HAT
• The financial boost of a successful $7 million public offering strengthened PaxMedica’s balance sheet and provided a financial platform for production and clinical trial initiatives
• The acquisition of suramin research assets from Rediscovery Life Sciences potentially expediting NDA submission for PAX-101
• A company update on clinical trial progress, with insights into future ASD trials
• Insight into PaxMedica’s business strategy to emphasize efficiency, production milestones, and key partnerships with organizations like Vox Nova
• The future vision of the company includes NDA plans for PAX-101 and potential advancements in autism treatment

The ASD therapeutics market was valued at $1.93 billion in 2022 and is expected to reach $3.42 billion by 2030, growing at a CAGR of 7.9%. The growing prevalence of this disease globally, in addition to the rising awareness about ASD, including available options and treatments, are key factors driving the market (https://ibn.fm/PvYf9). These estimates do not factor into the potential impact of treatments designed to address the core symptoms of ASD but provide insight into the market interest in therapeutics for ASD.

PaxMedica intends to continue into 2024 with the momentum it has gained with its achievements during the past year. The company is building a robust product pipeline to allow people with ASD to successfully integrate their behavior with others and improve their lives. Its lead programs, PAX-101 and PAX-102, utilize the company’s proprietary source of suramin sodium, a broadly acting APT known for over 100 years.

For more information, visit the company’s website at www.PaxMedica.com.

NOTE TO INVESTORS: The latest news and updates relating to PXMD are available in the company’s newsroom at https://ibn.fm/PXMD

• Mullen debuted its FIVE RS at this year’s CES show in Las Vegas
• Several car and auto publications reported on the unveiling of the new model
• Mullen anticipates beginning production of the FIVE RS in late 2025, with sales commencing in mid-2026

For the first time ever, Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, exhibited its line of commercial and consumer EVs at the Consumer Electronics Show(R) (“CES”) in Las Vegas. In addition to displaying its line of vehicles, the company also debuted its high-performance EV crossover, the Mullen FIVE RS; the world debut of the new vehicle garnered coverage in several car and auto magazines.

In its coverage, CarScoops notes that the Mullen FIVE RS has an intriguing design, big performance claims and a production date set for late 2025 (https://ibn.fm/nWYyZ). The article pointed out key features of Mullen’s latest offering, including its fast-charging capabilities, integrated infotainment system, artificial intelligence-based personal assistant called Persona, facial recognition technology and level 2+ driver assistance tech.

“Although seeing EVs with impressive performance figures is nothing new, it’s still a little surprising to encounter an electric crossover making promises of this magnitude,” the article stated. “Equipped with dual motors residing at the front and rear axles, the FIVE RS boasts a staggering 1,000 hp (746 kW/1,014 PS) and over 850 lb-ft (1,151 Nm) at its disposal, with Mullen claiming that it will be able to reach 60 mph (96 km/h) in under two seconds. Even more impressively, the automaker promises that its crossover will be capable of reaching a top speed of 200 mph (322 km/h) or even higher. . . . Mullen anticipates commencing production of the FIVE RS in late 2025, with sales set to commence in mid-2026. Subsequent versions of the SUV, including the $55,000 entry-level variant (originally slated for late last year), will follow in due course.”

AutoCar magazine noted that the electric super-crossover may be a rival to the Tesla Model X Plaid and Lucid Air Dream Edition (https://ibn.fm/SRtew). The article noted that Mullen CEO David Michery “gave few technical details away at the car’s unveiling but did confirm that the RS features a twin-motor, four-wheel-drive powertrain and 800V charging architecture that is said to allow for a 0–80% top-up in just 21 minutes.”

The article also reported that the car will be fitted with six- and four-piston Brembo brake calipers clamping carbon-ceramic discs, an ultra-performance race-track mode for maximum power and more engaging steering, and an AI-powered voice assistant with facial-recognition technology. The article quoted Michery as saying that “from the inception of Mullen, it has been my mission to bring an ultra-high-performance EV to market. The FIVE RS is intended to be one of the fastest vehicles on the planet, competing with some of the best and most well-known and regarded automotive marques.”

Road Track reported that the sporty new model is “ready to challenge Tesla and Lucid in the performance EV space. . . . Known as the Mullen FIVE RS, this electric crossover promises to bring over 1000 hp and a sub-2.0-second 0-60 mph sprint” (https://ibn.fm/OtB4S).

Calling the FIVE RS “a hotter variant of the brand’s FIVE SUV,” the article noted that the EV is powered by a 100-kWh battery pack that feeds a pair of electric motors to provide all-wheel drive and more than 1000 horsepower and 850-pound feet of torque. The design includes a two-speed sequential transmission sitting with either motor, which Mullen says will help the sleek SUV hit 60 mph in less than two seconds. In addition, the article reported that a set of either 21- or 22-inch wheels will cover carbon Brembo brakes at all four corners and will come wrapped in performance rubber. Mullen is working to reach 300 miles per charge, the article stated.

The Consumer Technology Association, which owns and produces the consumer technology trade show, expected 130,000 attendees and more than 4,000 exhibitors at this year’s event. CES is the most powerful tech event in the world, has established itself as the proving ground for breakthrough technologies and global innovators, and is the only trade show that showcases the entire tech landscape at one event (https://ibn.fm/4WOWp).

During CES, Mullen displayed the following vehicles: the Mullen ONE Class 1 Commercial EV Cargo Van; the Mullen THREE Class 3 Commercial Low Cab Forward; the Box Truck (ToughLite Upfit); the Service Truck (Phenix Truck Bodies Upfit); the Bollinger B1 Electric SUV; the Bollinger B2 Electric Pick Up; and the Bollinger B4 Class 4 Chassis Cab and Box Truck. In addition, on Jan. 9, at 11 a.m. PT, the company unveiled the Mullen FIVE RS, a high-performance variant of its flagship EV crossover (https://ibn.fm/geHrv).

Mullen Automotive is a Southern California-based automotive company building the next generation of electric vehicles in its two United States-based manufacturing and assembly plants. Mullen’s EV development portfolio includes the Mullen FIVE Crossover and FIVE RS High-Performance Sport Crossover EVs, Mullen GT and GTRS EV Supercars, Mullen PowerUP Mobile EV Charging Truck, Mullen-GO Commercial Urban Delivery EV, Mullen Commercial Class 1-3 EVs, and Bollinger Motors, which features the B1 and B2 electric SUV trucks and Class 4-6 commercial offerings. On Sept. 7, 2022, Bollinger Motors became a majority-owned EV truck company of Mullen Automotive, and on Dec. 1, 2022, Mullen closed on the acquisition of all Electric Last Mile Solutions (“ELMS”) assets, including all IP and a 650,000-square-foot plant in Mishawaka, Indiana.

For more information about the company, visit www.MullenUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN

Businesses, suppliers, leaders, and professionals across the mining spectrum are cordially invited to attend MiningNews Select 2024 at the Sydney Masonic Centre on March 18-19, 2024. This premier event offers companies engaged in gold and other mining resources an unparalleled opportunity to leverage the expansive reach, knowledge, and networking prospects it provides.

Investors will have the chance to engage directly with mining companies in intimate one-to-one discussions, exploring a plethora of potential investment avenues. With over 400 investor meetings, 40+ influential speakers, and a gathering of 250+ private and institutional investors, the event promises over 15 hours of robust networking opportunities.

A notable lineup of 30+ aspiring miners and companies will present their top-rated projects and services to an audience of over 150 institutional and retail investors. Backed by an expert panel of industry veterans, mining companies will have ample support to foster connections, forge partnerships, and cultivate business ties through personalized meetings and discussions.

The mining companies showcased at the MiningNews event are meticulously selected by the MiningNews team, renowned for their rigorous research and analysis. This ensures a curated list of companies boasting outstanding talents and prospects, offering investors a gateway to discovering promising mining ventures with a bright future.

To facilitate meaningful interactions, event organizers have arranged branded booths equipped with screens, enabling mining companies to host focused investor meetings. With over 35 years of experience closely intertwined with the Australian mining sector and investment markets, the team behind MiningNews orchestrates these well-curated events with precision.

Their research team, armed with 24 different metrics, has distilled them into 13 key metrics to identify the top mining projects. By providing investors with clear insights into market drivers and offering mining companies an optimal platform to showcase their capabilities, MiningNews empowers stakeholders to navigate the industry landscape with confidence and clarity.

To learn more, please visit https://ibn.fm/N5brp

• “In the dynamic world of investments, electric boat stocks are gaining momentum,” reports InvestorPlace
• The article calls Vision Marine a key player in the electric boat stocks market
• VMAR’s recent partnerships, market expansion and production enhancements point to potential growth and innovation

As investors pay increasing attention to potential involvement in clean, green-energy companies, the idea of sustainability is becoming more of a priority in sectors across the board. Vision Marine Technologies (NASDAQ: VMAR), a global leader and innovator in the performance electric recreational boating industry, is capturing attention and was recently spotlighted in an InvestorPlace article titled “Three Electric Boat Stocks That Will Sail Higher by 2024” (https://ibn.fm/ZFu5W).

“In the dynamic world of investments, electric boat stocks are gaining momentum,” the article stated. “These ‘e-boat stocks’ blend innovation with eco-sustainability. They mark a significant shift in the maritime sector. Traditionally high in emissions, this industry is now embracing green technology.

“Electric boat stocks are not just eco-friendly; they promise strong growth potential,” the article continued. “As renewable energy gains traction, maritime transport is also transforming. Electric propulsion and advanced batteries are key. They position e-boats as leaders in this emerging market. Investing in e-boat stocks goes beyond finances; it’s an eco-commitment. These companies are reducing the maritime industry’s carbon footprint. They offer sustainable, cost-effective solutions. With stricter environmental regulations, the shift to electric boats is inevitable.”

The article calls Vision Marine a key player in the electric boat stocks market, noting that despite some challenges, the company’s recent “strategic moves suggest a promising future in the electric boating sector.” The article noted VMAR’s partnership with 4ocean, along with its expansion into the pontoon market, which shows a “strategic diversification,” a move that InvestorPlace says “could be a game-changer for Vision Marine, showcasing its adaptability and innovation in the market.”

The article observes that “the company’s acquisition of industrial tooling to enhance its production capabilities is a strategic step. It aims to support the production of over 10,000 battery packs annually, meeting the increasing demand for electric marine propulsion systems.

Despite financial headwinds, Vision Marine Technologies is positioning itself as a forward-thinking leader in the electric boat industry. Vision Marine’s commitment to sustainability and market diversification might steer it towards a more prosperous future despite current challenges.”

As the global leader in the electric recreational boating industry serving both OEMs and consumers, Vision Marine is pioneering the clean-energy transition on the water by selling 100% electric boats, outboard motors and technology throughout the marine industry. In addition, the company strives to be a guiding force for change and an ongoing driving factor in fighting the problems associated with waterway pollution by disrupting the traditional boating industry with electric power.

For more information, visit the company’s website at www.VisionMarineTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to VMAR are available in the company’s newsroom at https://ibn.fm/VMAR

• Research forecasts global medical marijuana space will see CAGR of 22.32% over the next decade
• Several key factors contribute to double-digit growth
• MedCana has assembled a team of pharmaceutical scientists who are some of the world’s most respected chemists

Recent forecasts for the global medical marijuana sector indicate significant growth, a trend that Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) is paying close attention to. A global infrastructure and holding company in the cannabis industry, MedCana is on a mission to become the world’s premier resource for pharmaceutical cannabis products.

The recent ResarchAndMarket.com article reported that the global medical marijuana market size was estimated to be $16.88 billion in 2023 and is expected to reach at $154.83 billion by 2034, with a CAGR of 22.32% during the 2024–2034 forecast period (https://ibn.fm/ZyJ3m). “Growing awareness regarding various therapeutic applications of the marijuana, a surge in permitting the usage of medical marijuana, increasing adoption of cannabis in therapeutic applications, rising research and development activities, growing prevalence of chronic diseases, and increase in acquisition of market players for the manufacturing of advanced medical products are some of the key factors boosting the market growth,” the article stated.

“The North America region is anticipated for the highest revenue share during the forecast period, owing to the surge in cannabis legalization and increasing product launches by major market players,” the article continued. “Increased launch of advanced medical products is predicted to boost the market growth during the forecast period. Medical marijuana, also known as medical cannabis, is a marijuana plant extract utilized to alleviate symptoms, illnesses, and various health conditions. Numerous North American states have relaxed laws regarding cannabis use, both for medical and recreational purposes.”

The article also noted that many other countries worldwide are following North America’s lead by legalizing cannabis. “The increasing trend of cannabis decriminalization is expected to significantly boost the development and launch of medical marijuana,” the report concluded.

With this backdrop of growing awareness and acceptance of medical cannabis, MedCana is well positioned to become an industry leader. The company has assembled a team of pharmaceutical scientists that are some of the most respected chemists in the world (https://ibn.fm/ClWNH). These experts work closely with MedCana partners and customers to create premium pharmaceutical-grade cannabis extracts that will meet the growing worldwide demand for high-quality products.

MedCana has established five companies focused on pharmaceutical cannabis production, as well as a software company focused on managing processes for plant-to-patient operations. In addition, the company recently rounded out its portfolio of holdings with the acquisition of an irrigation and greenhouse technology company.

The company’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts globally.

For more information, visit the company’s website at www.MedCana.net.

NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://ibn.fm/SFWJ

Businesses, leaders, enthusiasts, and service providers of the cannabis spectrum are all invited to the NECANN Boston Convention, the 2nd largest B2B cannabis industry event across the globe. Since its 70th booth convention back in 2015, NECANN has come a long way. This year’s convention will feature over 350 exhibitors, several workshops, five full programming tracks, and a day-long financial/investor summit. The age limit to attend the conference is 18+ unless accompanied by a guardian.

The NECANN event is a phenomenal business platform attracting the New England cannabis trading community and other visitors. Influential cannabis industry leaders will be at the event, offering critical knowledge and developing industry insights. Experts will share strategies, ideas, and trends in the cannabis industry, while attendees harness the latest growth opportunities the platform offers. Enjoy unique experiences of networking and communication among peers, investors, and industry leaders.

Discussions will cover a number of important topics ranging from 280 changes and cannabis exit strategies, to insights from experts on sourcing diverse products, exploring funding through social equity programs, building a meaningful business network, and other subjects. Industry leaders will also explain the importance of community involvement, and how data analytics can impact business performance. In addition, the panel will talk about illicit cannabis operators based on recent numbers provided to them.

The NECANN  Boston Convention offers numerous business and growth avenues to the cannabis community. You will learn the latest industry trends and technologies to stay competitive in the fast-growing cannabis industry.

Due to popular demand, a THIRD exhibit hall, along with more programming and workshops, will be added.

To learn more, visit https://ibn.fm/fAdy7